myTomorrows

@myTomorrows

We provide patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitate access to medicines in development

Amsterdam - New York
Vrijeme pridruživanja: travanj 2013.

Tweetovi

Blokirali ste korisnika/cu @myTomorrows

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @myTomorrows

  1. prije 7 sati

    Interesting Blogpost by Marjorie Speers on "Tackling the Costs that can impede Expanded Access" - - -

    Poništi
  2. 4. velj

    and are collaborating to create awareness and facilitate access to emerging therapies for patients with Pancreatic Cancer, which is one of the deadliest cancers. . -

    Poništi
  3. 4. velj

    Interesting survey: "43% of Patients Not Participating in Clinical Trials Said Option Never Discussed by Medical Team" - - -

    Poništi
  4. 29. sij

    The French Healthcare Authority has just released a 6-point action-plan to facilitate patient access to innovative & high-value medicines - -

    Poništi
  5. proslijedio/la je Tweet
    29. sij

    Our paper on language identification of short medical texts (tweets) is now downloadable at website Meet and ask in Valletta in February!

    Poništi
  6. 28. sij

    Our RWD lead Tobias Polak - sharing his insights on a manuscript with - on combining Real-World Data and Expanded Access - -

    Poništi
  7. 28. sij

    Our RWD lead and Janet Woodcock discussing EA and RWD -

    Poništi
  8. 27. sij

    Opening keynotes at the 3rd annual “Expanded Access” Summit in D.C. – Great line-up and program for the next 2,5 days - -

    Poništi
  9. 24. sij

    Pharma Industry Broadens Its Approach To Expanded Access- - -

    Poništi
  10. 8. sij

    Powerful story on how “clinical trial information, coordination is critical” for helping more patients - - -

    Poništi
  11. 24. pro 2019.

    Trial designs using real‐world data: The changing landscape of the regulatory approval process -

    Poništi
  12. 20. pro 2019.

    “Complexe medische zorg begrijpelijk maken voor iedere patient” - -

    Poništi
  13. 18. pro 2019.

    myTomorrows and Omeros Corporation collaborate to provide an Expanded Access program for Narsoplimab -

    Poništi
  14. 15. pro 2019.

    “When you don’t qualify for a clinical trial: Expanded Access might help” - - -

    Poništi
  15. 12. pro 2019.

    myTomorrows and Inmunotek announce a new EA program for recurrent Urinary Tract Infections - -

    Poništi
  16. proslijedio/la je Tweet
    12. pro 2019.

    talking about growing a (robotic) brain at our office , while prepares for a live demo. Thanks for coming, even despite two Uber vans turning us down as they didn't like the big robot 'coffin'!

    Poništi
  17. 10. pro 2019.

    Join Tobias Polak, our Real-World Data lead, for an interesting panel discussion with top industry experts at the 3rd Annual EA summit Jan- 27-29th in DC. - -

    Poništi
  18. 8. pro 2019.

    “Clinical trials saves lives, but formidable barriers remain” - - -

    Poništi
  19. 4. pro 2019.

    Your patient requests an investigational therapy: How to respond - - -

    Poništi
  20. 4. pro 2019.

    Huntington’s cliical trial opens a door to hope - but only if patients get in - -

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·